Vanguard Group Inc Revolution Medicines, Inc. Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 15,663,094 shares of RVMD stock, worth $1.06 Billion. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,663,094
Previous 15,761,691 0.63%
Holding current value
$1.06 Billion
Previous $580 Million 26.14%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$34.7 - $46.7 $3.42 Million - $4.6 Million
-98,597 Reduced 0.63%
15,663,094 $731 Million
Q2 2025

Aug 11, 2025
SELL
$31.13 - $41.98 $26.5 Million - $35.7 Million
-850,344 Reduced 5.12%
15,761,691 $580 Million
Q1 2025

May 09, 2025
SELL
$35.36 - $44.42 $17.1 Million - $21.5 Million
-484,420 Reduced 2.83%
16,612,035 $587 Million
Q4 2024

Feb 11, 2025
BUY
$42.97 - $60.6 $93.9 Million - $132 Million
2,185,082 Added 14.65%
17,096,455 $748 Million
Q3 2024

Nov 13, 2024
BUY
$36.92 - $47.94 $19.7 Million - $25.6 Million
533,076 Added 3.71%
14,911,373 $676 Million
Q2 2024

Aug 13, 2024
SELL
$30.14 - $40.68 $11.4 Million - $15.4 Million
-378,815 Reduced 2.57%
14,378,297 $558 Million
Q1 2024

May 10, 2024
BUY
$26.56 - $33.55 $3.26 Million - $4.12 Million
122,721 Added 0.84%
14,757,112 $476 Million
Q4 2023

Feb 14, 2024
BUY
$18.35 - $34.12 $91.6 Million - $170 Million
4,990,800 Added 51.75%
14,634,391 $420 Million
Q3 2023

Nov 14, 2023
BUY
$25.17 - $35.05 $7.63 Million - $10.6 Million
303,088 Added 3.24%
9,643,591 $267 Million
Q2 2023

Aug 14, 2023
BUY
$20.28 - $27.0 $769,626 - $1.02 Million
37,950 Added 0.41%
9,340,503 $250 Million
Q1 2023

May 15, 2023
BUY
$20.76 - $30.09 $36.1 Million - $52.4 Million
1,740,643 Added 23.02%
9,302,553 $201 Million
Q4 2022

Feb 10, 2023
BUY
$17.68 - $25.53 $10.2 Million - $14.8 Million
577,908 Added 8.27%
7,561,910 $180 Million
Q3 2022

Nov 14, 2022
BUY
$17.46 - $26.0 $24.7 Million - $36.8 Million
1,416,990 Added 25.45%
6,984,002 $138 Million
Q2 2022

Aug 12, 2022
SELL
$14.54 - $27.17 $7.14 Million - $13.3 Million
-490,919 Reduced 8.1%
5,567,012 $109 Million
Q1 2022

May 13, 2022
SELL
$17.31 - $26.4 $4.18 Million - $6.38 Million
-241,678 Reduced 3.84%
6,057,931 $155 Million
Q4 2021

Feb 14, 2022
BUY
$24.35 - $33.7 $1.45 Million - $2 Million
59,411 Added 0.95%
6,299,609 $159 Million
Q3 2021

Nov 12, 2021
BUY
$23.95 - $33.41 $23.3 Million - $32.5 Million
971,634 Added 18.44%
6,240,198 $172 Million
Q2 2021

Aug 13, 2021
BUY
$29.0 - $47.44 $153 Million - $250 Million
5,268,564 New
5,268,564 $167 Million

Others Institutions Holding RVMD

# of Institutions
356
Shares Held
195M
Call Options Held
2.66M
Put Options Held
945K
View Full List

About Revolution Medicines, Inc.

RVMD Quotes by TradingView
  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $5.94B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email